APA (7th ed.) Citation

Rogers, C. A., Dick, A., Peto, T., Wilson, R., Keane, P. A., Denniston, A. K., . . . Beare, N. A. V. Adalimumab vs placebo as add-on to Standard Therapy for autoimmune Uveitis: Tolerability, Effectiveness and cost-effectiveness—a protocol for a randomised controlled trial (ASTUTE trial). BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Rogers, Chris A., et al. Adalimumab Vs Placebo as Add-on to Standard Therapy for Autoimmune Uveitis: Tolerability, Effectiveness and Cost-effectiveness—a Protocol for a Randomised Controlled Trial (ASTUTE Trial). BMJ Publishing Group.

MLA (9th ed.) Citation

Rogers, Chris A., et al. Adalimumab Vs Placebo as Add-on to Standard Therapy for Autoimmune Uveitis: Tolerability, Effectiveness and Cost-effectiveness—a Protocol for a Randomised Controlled Trial (ASTUTE Trial). BMJ Publishing Group.